Richard A Scolyer

Prof. Richard Scolyer AO, BMedSci, MBBS, MD, FRCPA, FRCPath, FAHMS is Snr Staff Specialist, Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; former Co-Medical Director and current Faculty Member of, Melanoma Institute Australia; Conjoint Professor, Faculty of Medicine & Health, The University of Sydney. He provides a clinical consultation service for the diagnosis of difficult pigmented lesions & receives more than 2000 cases for opinion from Australasia & beyond annually. He integrates his clinical practice with co-leading an award-winning translational melanoma research laboratory. His record includes co-authoring more than1000 peer reviewed publications, books and/or book-chapters in prestigious journals such as New England Journal of Medicine, Lancet, Nature, Cell, Nature Genetics, Lancet Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute & Cancer Discovery with >111548 citations and a H-index of 144 (Google Scholar as at 6 Mar '26). He has presented on more than 450 occasions at conferences globally. In Jan '24, he & his colleague Prof. Long were jointly named 2024 Australians of the Year having been jointly named as NSW 2024 Australians of the Year in Nov '23. He received the Society for Melanoma Research (SMR) 2023 Lifetime Achievement Award in Nov '23. In May '23, he received the International Academy of Pathology’s “Distinguished Pathology Award” for his outstanding contribution to the discipline of anatomical pathology. In Nov '23, he received the 2023 Founders’ Award by The American Society of Dermatopathology (ASDP) . In June '21, he was appointed Officer of the Order of Australia (AO) for distinguished service to medicine, particularly in the field of melanoma and skin cancer by The Governor-General of the Commonwealth of Australia. In '20, he received the NSW Premier's Award for Outstanding Cancer Researcher of the Year, the Royal College of Pathologists of Australasia (RCPA) Distinguished Fellow Award 2020, The University of Sydney’s 2020 Alumni Award for International Achievement & Clarivate Web of Science Group “Highly Cited Researcher in 2019-23”. He received the NSW Premier's Award for Outstanding Cancer Research in 2009, 2012-2014, 2016-2018, 2020-2022; the Thomson Reuters 2015 Citation Award in the Clinical Medicine category, the 2018 William O. Russell/Joanne Vandenberge Hill Award for Lifetime Achievement in Anatomical Pathology, MD Anderson Cancer Center, Research Australia’s 2018 GSK Award for Research Excellence, the 2019 American Society of Dermatopathology’s Elson B Helwig Award for excellence in dermatopathology, the 2021 University of Tasmania Distinguished Alumni Award and the 2021 University of Sydney’s Vice-Chancellor Award for Outstanding Research. According to Thomson Reuters ISI Web of Knowledge, Richard is the highest ever published scientist in the world in the field of melanoma pathology and he also has the highest H index in this field.